Cigna Evernorth unveils rebate-free pharmacy model to lower drug costs and simplify pricing for fully insured members by 2027.
Cigna Group’s announcement that it will end the highly criticized practice of accepting back-end drug manufacturer rebates ...
Axios on MSN
Cigna to move away from rebates in drug plans
Cigna on Monday announced a new drug-pricing arrangement in which discounts it negotiates with manufacturers will be passed ...
Cigna Group said on Monday it will eliminate prescription drug rebates in its own commercial health plans in 2027 and offer up-front discounts at its pharmacies, a shift it said would lower costs for ...
For those paying the full cost of medications, the new model will reduce the monthly cost for brand-name prescriptions by an ...
13don MSN
Rising Drug Tariffs Loom: UnitedHealthcare And Cigna Plans To Check In Medicare Open Enrollment
Starting October 1, the U.S. is taking a hard stance on pharmaceutical manufacturing: Imported brand-name, patented drugs ...
The stock market pummeled Cigna after the company revealed its new plan to ditch pharmacy benefit rebates will lower that segment’s profit ...
Cigna announced Monday morning that what it's calling a "new era" for its PBM unit is built on three core elements: ...
Overall, Cigna expects earnings to grow next year after posting a solid third quarter. But investments in a new PBM model and ...
The Cigna Group reported third quarter net income of nearly $2 billion despite rising costs in the health plans it sells.
But Cigna shares tumbled roughly 10% following the market open after Cordani told investors the pharmacy benefits segment, which accounts for roughly 30% of operating earnings, will face margin ...
Cigna Group on Thursday warned of margin pressure over the next two years as its pharmacy benefit management business ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results